63 related articles for article (PubMed ID: 7183527)
1. Surface ultrastructural changes of percoll separated splenic lymphocytes from syngeneic & allogeneic mice with transplanted ascites fibrosarcoma tumour.
Basu S; Chaudhuri S; Roy B
Indian J Exp Biol; 1982 Apr; 20(4):277-81. PubMed ID: 7183527
[No Abstract] [Full Text] [Related]
2. Ultrastructural & fluorescence microscopical observations on the effect of cis-dichloro-diammine platinum (II) on the surface of tumor & normal cells.
Sodhi A; Prasad SB
Indian J Exp Biol; 1981 Apr; 19(4):328-32. PubMed ID: 7196883
[No Abstract] [Full Text] [Related]
3. [Effect of exogenous DNA on the growth of transplantable tumors].
Nikolin VP; Popova NA; Sebeleva TE; Strunkin DN; Rogachev VA; Semënov DV; Bogachev SS; Iakubov LA; Shurdov MA
Vopr Onkol; 2006; 52(1):66-9. PubMed ID: 16715707
[TBL] [Abstract][Full Text] [Related]
4. [Analytic studies of lipids in ascites tumor cells separated by density gradient].
Holczinger L; Kremmer T
Acta Histochem Suppl; 1975; 15():35-40. PubMed ID: 829948
[No Abstract] [Full Text] [Related]
5. A modified enzymatic technique for production of cell suspensions of a murine fibrosarcoma.
Penning JJ; LeVan JH
J Natl Cancer Inst; 1981 Jan; 66(1):85-7. PubMed ID: 6256574
[TBL] [Abstract][Full Text] [Related]
6. [Components of Ehrlich ascites tumor cell surface].
Makovitzky J
Acta Histochem Suppl; 1984; 29():121-7. PubMed ID: 6201950
[No Abstract] [Full Text] [Related]
7. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
Harada M; Matsuzaki G; Yoshikai Y; Kobayashi N; Kurosawa S; Takimoto H; Nomoto K
Cancer Res; 1993 Jan; 53(1):106-11. PubMed ID: 8093229
[TBL] [Abstract][Full Text] [Related]
8. [Reduced antitumoral and suppressor activity of nonadherent bone marrow cells during culturing in a mixture with supernatant of Ehrlich tumor].
Bel'skiĭ IuP; Agranovich IM; Kusmartsev SA
Biull Eksp Biol Med; 1994 May; 117(5):514-7. PubMed ID: 9296706
[No Abstract] [Full Text] [Related]
9. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
Leach DR; Callahan GN
J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
[TBL] [Abstract][Full Text] [Related]
10. Changes in SCM-responses of lymphocytes in mice after implantation with Ehrlich ascites cells.
Cercek L; Cercek B
Eur J Cancer (1965); 1981 Feb; 17(2):167-71. PubMed ID: 7262153
[No Abstract] [Full Text] [Related]
11. [Effect of the nucleic acids from the ascitic fluid of Ehrlich's tumor on its transplantability].
Belokhvostov AS; Grikurova NK
Vopr Onkol; 1981; 27(12):56-9. PubMed ID: 7324403
[TBL] [Abstract][Full Text] [Related]
12. HSP47 as a possible marker for malignancy of tumors in vivo.
Morino M; Yasuda T; Shirakami T; Kiyosuke Y; Yoshimura M; Furusho T; Yoshikumi C
In Vivo; 1994; 8(3):285-8. PubMed ID: 7803705
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HSP47 during the transition from solid to ascitic form of Sarcoma 180 in vivo.
Shirakami T; Tsuzuki T; Iijima H; Ishikawa Y; Kiyosuke YI; Morino M; Yoshimura M; Yoshikumi C
In Vivo; 1995; 9(5):509-12. PubMed ID: 8900931
[TBL] [Abstract][Full Text] [Related]
14. Changes in the morphology of Ehrlich ascites tumour cells caused by hyperosmotic media.
Kajstura J; Korohoda W
Folia Histochem Cytobiol; 1988; 26(2):91-7. PubMed ID: 3208914
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of subpopulations of splenic cells from normal and fibrosarcoma - bearing mice towards syngeneic tumour cells.
Aroskar VS; Godbole CS; Chaubal KA
Tumori; 1983 Dec; 69(6):489-96. PubMed ID: 6607561
[TBL] [Abstract][Full Text] [Related]
16. Ehrlich ascites tumour cells have a more active mitochondrial polyamine transporter than that of rat liver.
Munsterhjelm E; Khawaja JA; Eriksson O; Saris NE
Biochem Mol Biol Int; 1995 Feb; 35(2):329-36. PubMed ID: 7663388
[TBL] [Abstract][Full Text] [Related]
17. Isolation of nucleoli from ELT cells: a quick new method that preserves morphological integrity and high transcriptional activity.
Vandelaer M; Thiry M; Goessens G
Exp Cell Res; 1996 Oct; 228(1):125-31. PubMed ID: 8892979
[TBL] [Abstract][Full Text] [Related]
18. Purine nucleotide levels in host tissues of Ehrlich ascites tumor-bearing mice in different growth phases of the tumor.
Siems WG; Grune T; Schmidt H; Tikhonov YV; Pimenov AM
Cancer Res; 1993 Nov; 53(21):5143-7. PubMed ID: 8221650
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell therapy for a murine mammary carcinoma.
Morecki S; Yacovlev E; Diab A; Slavin S
Cancer Res; 1998 Sep; 58(17):3891-5. PubMed ID: 9731499
[TBL] [Abstract][Full Text] [Related]
20. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
